
Company Number
09664461
Next Accounts
Mar 2026
Shareholders
-
Group Structure
View All
Industry
Activities of professional membership organisations
Registered Address
32 bury avenue, manchester, M16 0AT
Website
clirspec.orgPomanda estimates the enterprise value of THE INTERNATIONAL SOCIETY FOR CLINICAL SPECTROSCOPY at £227.7k based on a Turnover of £480.6k and 0.47x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of THE INTERNATIONAL SOCIETY FOR CLINICAL SPECTROSCOPY at £2k based on an EBITDA of £779 and a 2.53x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of THE INTERNATIONAL SOCIETY FOR CLINICAL SPECTROSCOPY at £69.4k based on Net Assets of £28.5k and 2.44x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
The International Society For Clinical Spectroscopy is a live company located in manchester, M16 0AT with a Companies House number of 09664461. It operates in the activities of professional membership organizations sector, SIC Code 94120. Founded in June 2015, it's largest shareholder is unknown. The International Society For Clinical Spectroscopy is a established, micro sized company, Pomanda has estimated its turnover at £480.6k with healthy growth in recent years.
Pomanda's financial health check has awarded The International Society For Clinical Spectroscopy a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 7 areas for improvement. Company Health Check FAQs
1 Strong
3 Regular
7 Weak
Size
annual sales of £480.6k, make it smaller than the average company (£838.8k)
- The International Society For Clinical Spectroscopy
£838.8k - Industry AVG
Growth
3 year (CAGR) sales growth of 10%, show it is growing at a similar rate (10.4%)
- The International Society For Clinical Spectroscopy
10.4% - Industry AVG
Production
with a gross margin of 72%, this company has a comparable cost of product (72%)
- The International Society For Clinical Spectroscopy
72% - Industry AVG
Profitability
an operating margin of 0.2% make it less profitable than the average company (1.1%)
- The International Society For Clinical Spectroscopy
1.1% - Industry AVG
Employees
with 6 employees, this is below the industry average (12)
6 - The International Society For Clinical Spectroscopy
12 - Industry AVG
Pay Structure
on an average salary of £49.6k, the company has an equivalent pay structure (£49.6k)
- The International Society For Clinical Spectroscopy
£49.6k - Industry AVG
Efficiency
resulting in sales per employee of £80.1k, this is less efficient (£111.9k)
- The International Society For Clinical Spectroscopy
£111.9k - Industry AVG
Debtor Days
it gets paid by customers after 16 days, this is earlier than average (23 days)
- The International Society For Clinical Spectroscopy
23 days - Industry AVG
Creditor Days
its suppliers are paid after 0 days, this is quicker than average (28 days)
- The International Society For Clinical Spectroscopy
28 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- The International Society For Clinical Spectroscopy
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 49 weeks, this is less cash available to meet short term requirements (94 weeks)
49 weeks - The International Society For Clinical Spectroscopy
94 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 56.8%, this is a higher level of debt than the average (26.9%)
56.8% - The International Society For Clinical Spectroscopy
26.9% - Industry AVG
The International Society For Clinical Spectroscopy's latest turnover from June 2024 is estimated at £480.6 thousand and the company has net assets of £28.5 thousand. According to their latest financial statements, The International Society For Clinical Spectroscopy has 6 employees and maintains cash reserves of £35.5 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | |
---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||
Other Income Or Grants | |||||||||
Cost Of Sales | |||||||||
Gross Profit | |||||||||
Admin Expenses | |||||||||
Operating Profit | |||||||||
Interest Payable | |||||||||
Interest Receivable | |||||||||
Pre-Tax Profit | |||||||||
Tax | |||||||||
Profit After Tax | |||||||||
Dividends Paid | |||||||||
Retained Profit | |||||||||
Employee Costs | |||||||||
Number Of Employees | 6 | 6 | 7 | 8 | 8 | ||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | |
---|---|---|---|---|---|---|---|---|---|
Tangible Assets | |||||||||
Intangible Assets | |||||||||
Investments & Other | |||||||||
Debtors (Due After 1 year) | |||||||||
Total Fixed Assets | |||||||||
Stock & work in progress | |||||||||
Trade Debtors | 22,128 | 1,565 | 7,077 | 35 | 750 | 6,015 | 6,025 | 3,535 | 1,740 |
Group Debtors | |||||||||
Misc Debtors | 8,190 | 16,702 | 5,016 | 4,208 | 4,071 | 18,800 | 9,040 | 5,736 | |
Cash | 35,518 | 31,234 | 24,855 | 13,467 | 14,333 | 10,183 | 10,823 | 13,440 | 1,990 |
misc current assets | 138 | 946 | |||||||
total current assets | 65,836 | 49,501 | 36,948 | 17,710 | 19,292 | 35,944 | 25,888 | 22,711 | 3,730 |
total assets | 65,836 | 49,501 | 36,948 | 17,710 | 19,292 | 35,944 | 25,888 | 22,711 | 3,730 |
Bank overdraft | |||||||||
Bank loan | |||||||||
Trade Creditors | 1 | 208 | 1,569 | 2,079 | 5,201 | 2,509 | 1,113 | 10 | |
Group/Directors Accounts | |||||||||
other short term finances | |||||||||
hp & lease commitments | |||||||||
other current liabilities | 37,381 | 22,738 | 16,981 | 893 | 600 | 23,390 | 10,696 | 13,120 | 420 |
total current liabilities | 37,382 | 22,946 | 18,550 | 2,972 | 5,801 | 25,899 | 11,809 | 13,130 | 420 |
loans | |||||||||
hp & lease commitments | |||||||||
Accruals and Deferred Income | |||||||||
other liabilities | |||||||||
provisions | |||||||||
total long term liabilities | |||||||||
total liabilities | 37,382 | 22,946 | 18,550 | 2,972 | 5,801 | 25,899 | 11,809 | 13,130 | 420 |
net assets | 28,454 | 26,555 | 18,398 | 14,738 | 13,491 | 10,045 | 14,079 | 9,581 | 3,310 |
total shareholders funds | 28,454 | 26,555 | 18,398 | 14,738 | 13,491 | 10,045 | 14,079 | 9,581 | 3,310 |
Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | |
---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||
Operating Profit | |||||||||
Depreciation | |||||||||
Amortisation | |||||||||
Tax | |||||||||
Stock | |||||||||
Debtors | 12,051 | 6,174 | 7,850 | -578 | -19,994 | 9,750 | 5,794 | 7,531 | 1,740 |
Creditors | -207 | -1,361 | -510 | -3,122 | 2,692 | 1,396 | 1,103 | 10 | |
Accruals and Deferred Income | 14,643 | 5,757 | 16,088 | 293 | -22,790 | 12,694 | -2,424 | 12,700 | 420 |
Deferred Taxes & Provisions | |||||||||
Cash flow from operations | |||||||||
Investing Activities | |||||||||
capital expenditure | |||||||||
Change in Investments | |||||||||
cash flow from investments | |||||||||
Financing Activities | |||||||||
Bank loans | |||||||||
Group/Directors Accounts | |||||||||
Other Short Term Loans | |||||||||
Long term loans | |||||||||
Hire Purchase and Lease Commitments | |||||||||
other long term liabilities | |||||||||
share issue | |||||||||
interest | |||||||||
cash flow from financing | |||||||||
cash and cash equivalents | |||||||||
cash | 4,284 | 6,379 | 11,388 | -866 | 4,150 | -640 | -2,617 | 11,450 | 1,990 |
overdraft | |||||||||
change in cash | 4,284 | 6,379 | 11,388 | -866 | 4,150 | -640 | -2,617 | 11,450 | 1,990 |
Perform a competitor analysis for the international society for clinical spectroscopy by selecting its closest rivals, whether from the OTHER SERVICE ACTIVITIES sector, other micro companies, companies in M16 area or any other competitors across 12 key performance metrics.
THE INTERNATIONAL SOCIETY FOR CLINICAL SPECTROSCOPY group structure
The International Society For Clinical Spectroscopy has no subsidiary companies.
Ultimate parent company
THE INTERNATIONAL SOCIETY FOR CLINICAL SPECTROSCOPY
09664461
The International Society For Clinical Spectroscopy currently has 6 directors. The longest serving directors include Mr Peter Gardner (Jun 2015) and Dr Alexander Henderson (Jun 2015).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Peter Gardner | England | 62 years | Jun 2015 | - | Director |
Dr Alexander Henderson | England | 58 years | Jun 2015 | - | Director |
Professor Nicholas Stone | England | 54 years | Jun 2015 | - | Director |
Professor Hugh Byrne | Ireland | 60 years | Jul 2015 | - | Director |
Professor Magorzata Baraska | England | 56 years | Feb 2017 | - | Director |
Professor Bayden Wood | England | 58 years | Feb 2017 | - | Director |
P&L
June 2024turnover
480.6k
+43%
operating profit
779.8
0%
gross margin
72.1%
-4.35%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
June 2024net assets
28.5k
+0.07%
total assets
65.8k
+0.33%
cash
35.5k
+0.14%
net assets
Total assets minus all liabilities
company number
09664461
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
94120 - Activities of professional membership organisations
incorporation date
June 2015
age
10
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
June 2024
previous names
N/A
accountant
MCKELLENS LIMITED
auditor
-
address
32 bury avenue, manchester, M16 0AT
Bank
-
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to the international society for clinical spectroscopy.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for THE INTERNATIONAL SOCIETY FOR CLINICAL SPECTROSCOPY. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|